VOR
VOR
US9290332074
Vor Biopharma Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
1.08B EUR
1B EUR
966.67M EUR
506.46M EUR
Enterprise Value
668.52M EUR
897.55M EUR
799.74M EUR
112.97M EUR
Valuation Multiples
Trailing P/E
0.11x
1.6x
--
--
Forward P/E
-5.22x
--
--
--
Price to Sales
--
--
--
--
Price to Book
--
--
--
--
EV/Revenue
--
--
--
--
EV/EBITDA
-5.7x
--
5.29x
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-7.37%
-14.05%
-15.58%
-22.18%
ende